143 related articles for article (PubMed ID: 22863838)
1. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities.
Ito K; Nakashima H; Watanabe M; Ishimura A; Miyahara Y; Abe Y; Yasuno T; Ifuku M; Sasatomi Y; Saito T
Nephrol Dial Transplant; 2012 Oct; 27(10):3899-907. PubMed ID: 22863838
[TBL] [Abstract][Full Text] [Related]
2. Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy.
Kanamaru Y; Nakao A; Shirato I; Okumura K; Ogawa H; Tomino Y; Ra C
J Am Soc Nephrol; 2002 Jun; 13(6):1527-33. PubMed ID: 12039982
[TBL] [Abstract][Full Text] [Related]
3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
4. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
Saito T; Matsunaga A; Oikawa S
Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.
Nong Z; Gonzalez-Navarro H; Amar M; Freeman L; Knapper C; Neufeld EB; Paigen BJ; Hoyt RF; Fruchart-Najib J; Santamarina-Fojo S
J Clin Invest; 2003 Aug; 112(3):367-78. PubMed ID: 12897204
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
[TBL] [Abstract][Full Text] [Related]
7. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
[TBL] [Abstract][Full Text] [Related]
9. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C
Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
[TBL] [Abstract][Full Text] [Related]
12. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
15. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.
Grainger DJ; Reckless J; McKilligin E
J Immunol; 2004 Nov; 173(10):6366-75. PubMed ID: 15528376
[TBL] [Abstract][Full Text] [Related]
17. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
[TBL] [Abstract][Full Text] [Related]
18. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
[TBL] [Abstract][Full Text] [Related]
19. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
